Ligand Pharmaceuticals Inc
NASDAQ:LGND

Watchlist Manager
Ligand Pharmaceuticals Inc Logo
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Watchlist
Price: 115.45 USD -5.43% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Ligand Pharmaceuticals Inc?
Write Note

Ligand Pharmaceuticals Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ligand Pharmaceuticals Inc
Net Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Net Income
$96.4m
CAGR 3-Years
26%
CAGR 5-Years
-32%
CAGR 10-Years
30%
Abbvie Inc
NYSE:ABBV
Net Income
$5.1B
CAGR 3-Years
-12%
CAGR 5-Years
10%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Income
$4.2B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income
$4.7B
CAGR 3-Years
-13%
CAGR 5-Years
17%
CAGR 10-Years
30%

See Also

What is Ligand Pharmaceuticals Inc's Net Income?
Net Income
96.4m USD

Based on the financial report for Jun 30, 2024, Ligand Pharmaceuticals Inc's Net Income amounts to 96.4m USD.

What is Ligand Pharmaceuticals Inc's Net Income growth rate?
Net Income CAGR 10Y
30%

Over the last year, the Net Income growth was 256%. The average annual Net Income growth rates for Ligand Pharmaceuticals Inc have been 26% over the past three years , -32% over the past five years , and 30% over the past ten years .

Back to Top